Bendamustine, bortezomib and prednisone for the treatment of patients with newly diagnosed multiple myeloma: results of a prospective phase 2 Spanish/PETHEMA trial.
Mateos MV, Oriol A, Rosinol L, de Arriba F, Puig N, Martin J, Martinez-Lopez J, Echeveste MA, Sarra J, Ocio E, Ramirez G, Martinez R, Palomera L, Payer A, Iglesias R, de la Rubia J, Alegre A, Chinea AI, Blade J, Lahuerta JJ, San Miguel JF.
Haematologica. 2015; 100: 1096-1102. FI: 5.814 (Q1).
Transcriptional repression by the HDAC4-RelB-p52 complex regulates multiple myeloma survival and growth.
Vallabhapurapu SD, Noothi SK, Pullum DA, Lawrie, CH, Pallapati R, Potluri V, Kuntzen C, Khan S, Plas DR, Orlowski RZ, Chesi M, Kuehl, W. Michael, Bergsagel PL, Karin M, Vallabhapurapu S.
Nat. Commun. 2015; 6. FI: 11.470 (Q1).
The circulating transcriptome as a source of non-invasive cancer biomarkers: concepts and controversies of non-coding and coding RNA in body fluids.
Fernandez-Mercado M, Manterola L, Larrea E, Goicoechea, I, Arestin M, Armesto M, Otaegui D, Lawrie CH.
J. Cell. Mol. Med. 2015; 19: 2307-2323. FI: 4.014 (Q1).
The influence of the size and aspect ratio of anisotropic, porous CaCO3 particles on their uptake by cells.
Parakhonskiy B, Zyuzin MV, Yashchenok A, Carregal-Romero S, Rejman J, Moehwald H, Parak WJ, Skirtach AG.
J. Nanobiotechnol. 2015; 13. FI: 4.115 (Q1).
Critical analysis of the stringent complete response in multiple myeloma: contribution of sFLC and bone marrow clonality.
Martinez-Lopez J, Paiva B, Lopez-Anglada L, Mateos MV, Cedena T, Vidriales MB, Saez-Gomez MA, Contreras T, Oriol A, Rapado I, Teruel AI, Cordon L, Blanchard MJ, Bengoechea E, Palomera L, de Arriba F, Cueto-Felgueroso C, Orfao A, Blade J, San Miguel JF, Lahuerta JJ, Grp Espanol Mieloma Multiple, Programa Estudio Terapeutica Hemop.
Blood. 2015; 126: 858-862. FI: 10.452 (Q1).
Conjugated Polymers As Molecular Gates for Light-Controlled Release of Gold Nanoparticles.
Sanroman-Iglesias M, Zhang KAI, Chuvilin A, Lawrie CH, Grzelczak M, Liz-Marzan LM.
ACS Appl. Mater. Interfaces. 2015; 7: 15692-15695. FI: 6.723 (Q1).
MGMT Expression Predicts PARP-Mediated Resistance to Temozolomide.
Erice O, Smith MP, White R, Goicoechea I, Barriuso J, Jones C, Margison GP, Acosta JC, Wellbrock C, Arozarena I.
Mol. Cancer Ther. 2015; 14: 1236-1246. FI: 5.683 (Q1).
MicroRNAs in Lymphoma: Regulatory Role and Biomarker Potential.
Fernandez-Mercado M, Manterola L, Lawrie CH.
Curr. Genomics. 2015; 16: 349-358. FI: 2.342 (Q3).
Phenotypic identification of subclones in multiple myeloma with different chemoresistant, cytogenetic and clonogenic potential.
Paíno T, Paiva B, Sayagués JM, Mota I, Carvalheiro T, Corchete LA, Aires-Mejía I, Pérez JJ, Sanchez ML, Barcena P, Ocio EM, San-Segundo L, Sarasquete ME, García-Sanz R, Vidriales MB, Oriol A, Hernández MT, Echeveste MA, Paiva A, Blade J, Lahuerta JJ, Orfao A, Mateos MV, Gutiérrez NC, San-Miguel JF.
Leukemia. 2015; 29: 1186-1194. FI: 10.431 (Q1).
Disruption of SF3B1 results in deregulated expression and splicing of key genes and pathways in myelodysplastic syndrome hematopoietic stem and progenitor cells.
Dolatshad H, Pellagatti A, Fernandez-Mercado M, Yip BH, Malcovati L, Attwood M, Przychodzen B, Sahgal N, Kanapin AA, Lockstone H, Scifo L, Vandenberghe P, Papaemmanuil E, Smith CWJ, Campbell PJ, Ogawa S, Maciejewski JP, Cazzola M, Savage KI, Boultwood J.
Leukemia. 2015; 29: 1092-1103. FI: 10.431 (Q1).
Antibiotic loaded nanocapsules functionalized with aptamer gates for targeted destruction of pathogens.
Kavruk M, Celikbicak O, Ozalp VC, Borsa BA, Hernandez FJ, Bayramoglu G, Salih B, Arica MY.
Chem. Commun. 2015; 51: 8492-8495. FI: 6.834 (Q1).
Light-Addressable and Degradable Silica Capsules for Delivery of Molecular Cargo to the Cytosol of Cells.
Ott A, Yu X, Hartmann R, Rejman J, Schuetz A, Ochs M, Parak WJ, Carregal-Romero S.
Chem. Mat. 2015; 27: 1929-1942. FI: 8.354 (Q1).
DNA-aptamer gating membranes.
Schaefer T, Ozalp VC. Schaefer T, Ozalp VC.
Chem. Commun. 2015; 51: 5471-5474. FI: 6.834 (Q1).
Particle-Based Optical Sensing of Intracellular Ions at the Example of Calcium – What Are the Experimental Pitfalls?.
Kantner K, Ashraf S, Carregal-Romero S, Carrillo-Carrion C, Collot M, del Pino P, Heimbrodt W, De Aberasturi D, Jimenez K, Uwe K, Lyubov I, Lelle M, Martinez de Baroja N, Montenegro J, Nazarenus M, Pelaz B, Peneva K, Gil P, Sabir N, Schneider LM, Shabarchina LI, Sukhorukov GB, Vazquez M, Yang F, Parak WJ.
Small. 2015; 11: 896-904. FI: 8.368 (Q1).
